Hälsa & medicin
5.6
Researchers develop antibody effective against multiple COVID variants
Scientists have identified a broadly neutralizing antibody, 19n01, that works against omicron subvariants and other concerning SARS-CoV-2 strains. The finding could inform next-generation vaccine design and therapeutic development as the virus continues to evolve, potentially reducing the need for frequent vaccine reformulations.
Originaltitel: 19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern